U.S. market Closed. Opens in 1 day 12 hours 4 minutes

CWBR | CohBar, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.5400 - 0.5610
52 Week Range 0.0010 - 1.0100
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 15,268
Average Volume 2,815
Shares Outstanding 2,906,930
Market Cap 1,571,196
Sector Healthcare
Industry Biotechnology
IPO Date 2017-12-15
Valuation
Profitability
Growth
Health
P/E Ratio -0.12
Forward P/E Ratio N/A
EPS -4.37
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 9
Country USA
Website CWBR
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
*Chart delayed
Analyzing fundamentals for CWBR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see CWBR Fundamentals page.

Watching at CWBR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CWBR Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙